Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Forbes

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Early Intervention in Psychiatry|September 4, 2020
Differences between Australian adolescents with eating disorder symptoms who are in treatment or not in treatment for an eating disorderNora Trompeter, Kay Bussey, Miriam K Forbes, et al.
BMC Immunology|April 30, 2024
The influence of neonatal BCG vaccination on in vitro cytokine responses to Plasmodium falciparumN L Messina, M Wang, E K Forbes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2025
Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR TrialNicole L Messina, Laure F Pittet, Emily K Forbes, et al.
Plos One|September 18, 2012
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding proteinEmily K Forbes, Simone C de Cassan, David Llewellyn, et al.
Eclinicalmedicine|February 2, 2024
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional studyAnna K Forbes, William Hinton, Michael D Feher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science|March 24, 2021
A detailed hierarchical model of psychopathology: From individual symptoms up to the general factor of psychopathologyMiriam K Forbes, Matthew Sunderland, Ronald M Rapee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Vaccine|December 3, 2025
Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trialNicole L Messina, Laure F Pittet, Emily K Forbes, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Early Intervention in Psychiatry|September 4, 2020
Differences between Australian adolescents with eating disorder symptoms who are in treatment or not in treatment for an eating disorderNora Trompeter, Kay Bussey, Miriam K Forbes, et al.
BMC Immunology|April 30, 2024
The influence of neonatal BCG vaccination on in vitro cytokine responses to Plasmodium falciparumN L Messina, M Wang, E K Forbes, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 22, 2025
Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR TrialNicole L Messina, Laure F Pittet, Emily K Forbes, et al.
Plos One|September 18, 2012
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding proteinEmily K Forbes, Simone C de Cassan, David Llewellyn, et al.
Eclinicalmedicine|February 2, 2024
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional studyAnna K Forbes, William Hinton, Michael D Feher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science|March 24, 2021
A detailed hierarchical model of psychopathology: From individual symptoms up to the general factor of psychopathologyMiriam K Forbes, Matthew Sunderland, Ronald M Rapee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Vaccine|December 3, 2025
Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trialNicole L Messina, Laure F Pittet, Emily K Forbes, et al.
Pageof 25